Cardiovascular Revascularization Medicine
Volume 7, Issue 2 , Page 82, April 2006

Is thrombin suppression adequate with low-dose heparin and eptifibatide versus high-dose heparin in patients undergoing peripheral percutaneous interventions?

Midwest Cardiovascular Research Foundation, Davenport, IA, USA

Biostatistics Department, Genesis Health System, Davenport, IA, USA

Case Western Reserve University, Cleveland, OH, USA

The Millennium Co., Cambridge, MA, USA

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S1553-8389(06)00028-5

doi:10.1016/j.carrev.2006.03.005

Cardiovascular Revascularization Medicine
Volume 7, Issue 2 , Page 82, April 2006

Article Tools